4 Grants
2023
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
Zhang, Xinna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA276680-01A1), $466,898USD, 2023-07-14 -- 2028-06-30
2022
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
Lu, Xiongbin and Zhang, Xinna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA260274-01A1), $501,827USD, 2022-01-01 -- 2026-12-31
2021
Targeting HER2-low breast cancer with 17p loss
Lu, Xiongbin⋅Schneider, Bryan P and Zhang, Xinna
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA203737-07), $535,448USD, 2016-04-01 -- 2026-04-30
2019
Identification of Therapeutic Vulnerability in Prostate Cancer Harboring Chromosome 17p Loss
Zhang, Xinna
U.S. Department Of Defense (Dod), Medical Research & Material Command/Congressionally Directed Medical Research Programs (ID: W81XWH2010201), $1,188,750USD, 2019-01-01 -- 2019-12-31